Latest papers

B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies.

Perspectives on the role of mTORC2 in B lymphocyte development, immunity and tumorigenesis.

Pathophysiology and therapeutic options in primary immune thrombocytopenia.

The dual nature of Ets-1: Focus to the pathogenesis of systemic lupus erythematosus

B cells and autoimmunity 2010. Proceedings of a conference. August 2010. Nara, Japan.

Alterations in peripheral blood B-cell populations in SHIV89.6P-infected macaques (Macacca fascicularis).

ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma.

Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.

[Rationale and clinical evidence for the use of rituximab in glomerular diseases].

Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2.

Acute hepatitis A virus infection without IgM antibodies to hepatitis A virus.

Regulatory role of natural killer (NK) cells on antibody responses to Brucella abortus.

CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.

Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disorders.

Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile.

Heterogeneity versus homogeneity of multiple sclerosis.

MMP9 is protective against lethal inflammatory mass lesions in the mouse colon.

Do RANKL inhibitors (denosumab) affect inflammation and immunity?

Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells.

Regulation of lymphocytes by nitric oxide.